Dr. Lino Ferreira
University of Coimbra, Portugal
Lino Silva Ferreira holds a Ph.D. in Biotechnology from the University of Coimbra (Portugal). He did postdoctoral work at INEB and MIT (USA) in the areas of stem cells, micro- and nanotechnologies. He joined the Center of Neurosciences and Cell Biology (CNC, University of Coimbra) in 2008. He has published more than 100 peer-reviewed papers and has 20 issued or pending patents– 8 of which have been licensed to companies in the biomedical industry. He is the director of the Biomaterials and Stem Cell-Based Therapeutics research group, CNC coordinator of the MIT-Portugal Program and the founder of the biotech companies Matera and CureMat Technologies. In 2012 he was awarded with a prestigious European Research Council starting grant and in 2016 an ERA Chair position at the University of Coimbra. His research group has interest in the development of nanomedicine platforms to modulate the activity of cells and in the generation of in vitro cardiovascular tissues from stem cells for drug screening and disease modelling.